Weekly Recap | PDS Biotechnology +173.14%, financing and board news lead the moveWeekly Review·9 hours agoPDSB-4.36%
Weekly Recap | PDS Biotechnology +34.05%, most brokers rate it buyWeekly Review·Sep 12 at 06:35 AMPDSB-4.36%
